AbbVie (ABBV) Treasury Shares (2013 - 2026)

AbbVie (ABBV) has 14 years of Treasury Shares data on file, last reported at $10.6 billion in Q1 2026.

• Treasury Shares for Q1 2026 came in at $10.6 billion, up 16.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.6 billion (up 16.13% YoY), and the FY2025 annual result was $9.1 billion, up 11.52% from the prior year.
• Treasury Shares climbed to $10.6 billion in Q1 2026 per ABBV's latest filing, from $9.1 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $77.1 million in Q1 2026 and troughed at $5.0 million in Q1 2025.
• A 5-year average of $22.1 million and a median of $10.0 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares soared 51.99% in 2022, then climbed 11.52% in 2025.
• A 5-year view of Treasury Shares shows it stood at $4.6 billion in 2022, then surged by 42.21% to $6.5 billion in 2023, then advanced by 25.53% to $8.2 billion in 2024, then rose by 11.52% to $9.1 billion in 2025, then advanced by 16.02% to $10.6 billion in 2026.
• Business Quant data shows ABBV's Treasury Shares at $10.6 billion in Q1 2026, $9.1 billion in Q4 2025, and $9.1 billion in Q3 2025.